# Inducing Immune Quiescence to Prevent HIV Infection in Women

> **NCT02079077** · NA · COMPLETED · sponsor: **University of Manitoba** · enrollment: 91 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Acetylsalicylic Acid (ASA)
- **DRUG:** Hydroxychloroquine (HCQ)

## Key facts

- **NCT ID:** NCT02079077
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-12
- **Final completion:** 2018-01-01
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2019-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02079077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02079077, "Inducing Immune Quiescence to Prevent HIV Infection in Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02079077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*